Pharmacist in Deadly Meningitis Outbreak Cleared of Murder - NBC10 Boston
National & International News
The day’s top national and international news

Pharmacist in Deadly Meningitis Outbreak Cleared of Murder

Prosecutors said Glenn Chin failed to properly sterilize the drugs and instructed his staff to use expired ingredients and ignore cleaning

Find NBC Boston in your area

Channel 10 on most providers

Channel 15, 60 and 8 Over the Air

    Winter Olympics PyeongChang 2018 Medal Count
    Country
    Total
    1
    Norway
    119828
    2
    Germany
    106420
    3
    Canada
    65617
    processing...

    NEWSLETTERS

    Pharmacist Found Not Guilty of Second-Degree Murder for Meningitis Deaths

    After more than a five- week-long trial at the federal courthouse in South Boston, a  jury decided on the charges against Glenn Chin.

    (Published Wednesday, Oct. 25, 2017)

    A Massachusetts pharmacist charged in a deadly meningitis outbreak has been cleared of murder in the 2012 meningitis outbreak that killed 64 people.

    A Boston jury on Wednesday found Glenn Chin not guilty of second-degree murder but convicted him on mail fraud and racketeering charges.

    Chin was the supervisory pharmacist at the now-closed New England Compounding Center in Framingham, where he oversaw the rooms where the drugs were made.

    The outbreak of fungal meningitis and other infections was blamed on contaminated injections of medical steroids, given mostly to people with back pain.

    Pharmacist Found Guilty of Racketeering in NECC Outbreak

    [NECN] Pharmacist Found Guilty of Racketeering in Meningitis Outbreak Case

    Jurors in Glenn Chin's case reached their verdict on Wednesday afternoon. They had been deliberating in Boston's federal courthouse since Monday.

    (Published Wednesday, Oct. 25, 2017)

    Prosecutors said Chin failed to properly sterilize the drugs and instructed his staff to use expired ingredients and ignore cleaning. In a statement after the verdict, the prosecution said, "As a licensed pharmacist, Mr. Chin took an oath to protect patients, but instead deliberately violated safety regulations, causing the largest public health crisis caused by a pharmaceutical drug in U.S. history."

    Chin's attorneys argued that he was not responsible for the deaths. They said prosecutors did not show that he caused the drugs to become contaminated.

    "He's remorseful for what happened. He doesn't feel personally responsible because he didn't commit murder," one of Chin's attorneys said.

    Chin was one of more than a dozen employees charged following the outbreak.

    Barry Cadden, NECC's owner and chief pharmacist, was found guilty of fraud and racketeering charges earlier this year, but not guilty of second-degree murder. He tearfully apologized to victims as he was sentenced in June to nine years in prison. 

    Besides the 64 people who died, more than 700 were sickened. Illnesses and deaths in 20 states were traced to the contaminated steroids. Indiana, Michigan and Tennessee were hit hardest.

    Split Verdict in Deadly Meningitis Trial

    [NECN] Split Verdict in Deadly Meningitis Trial

    Barry Cadden, the former head of the New England Compounding Center, was convicted of racketeering and other charges, but he was acquitted of murder charges in the meningitis outbreak that killed 64 people across the country.

    (Published Wednesday, March 22, 2017)

    The scandal prompted increased scrutiny on compounding pharmacies, which differ from ordinary drugstores in that they custom-mix medications and supply them directly to hospitals and doctors. In 2013, in reaction to the outbreak, Congress increased federal oversight of such pharmacies.

    NECC filed for bankruptcy after getting hit with hundreds of lawsuits. It and several related companies reached a $200 million settlement with victims and their families.

    Chin will appear for court for sentencing on Jan. 30, and faces up to 20 years in prison. 


    Get the latest from NBC Boston anywhere, anytime:

    App

    Download our FREE app for iPhone, iPad and Android. You can also follow us on Facebook, Twitter and Instagram, and sign up for our e-mail newsletters.